These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27226950)

  • 1. Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany.
    Brehler R; Klimek L; Vogelberg C; Werfel T; Pfaar O; Hamelmann E
    Allergo J Int; 2016; 25():38-43. PubMed ID: 27226950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Allergen immunotherapy - a position paper of the German society for allergology and clinical immunology].
    Kleine-Tebbe J; Fuchs T; Klimek L; Kühr J; Lepp U; Niggemann B; Rakoski J; Renz H; Saloga J; Simon J
    Pneumologie; 2001 Sep; 55(9):438-44. PubMed ID: 11536068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy.
    Pfaar O; Hamelmann E; Taube C; Wagenmann M; Wedi B; Werfel T; Bartel D; Bonertz A; Hartenstein D; Kaul S; Mahler V; Worm M
    Allergol Select; 2023; 7():229-235. PubMed ID: 38143938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen Immunotherapy (AIT) in children: a vulnerable population with its own rights and legislation - summary of EMA-initiated multi-stakeholder meeting on Allergen Immunotherapy (AIT) for children, held at Paul-Ehrlich-Institut, Langen, Germany, 16.1.2019.
    Mahler V; Mentzer D; Bonertz A; Muraro A; Eigenmann P; Bousquet J; Halken S; Pfaar O; Jutel M; Wahn U; Vieths S; Kaul S
    Clin Transl Allergy; 2020; 10():28. PubMed ID: 32612805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen immunotherapy phase II trials: Challenges in dose finding.
    Kleine-Tebbe J; Kaul S; Mösges R
    Allergol Select; 2019; 3(1):1-8. PubMed ID: 32176223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen-specific immunotherapy and evidence: A European regulatory perspective.
    Bartel D; Bonertz A; Hartenstein D; Kaul S; Lauer I; Reeb C; Rösner-Friese K; Sliva K; Zimmer J; Vieths S; Mahler V
    Allergol Select; 2023; 7():198-210. PubMed ID: 38143937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese Guideline on allergen immunotherapy for allergic rhinitis.
    Bao Y; Chen J; Cheng L; Guo Y; Hong S; Kong W; Lai H; Li H; Li H; Li J; Li T; Lin X; Liu S; Liu Z; Lou H; Meng J; Qiu Q; Shen K; Tang W; Tao Z; Wang C; Wang X; Wei Q; Xiang L; Xie H; Xu Y; Zhang G; Zhang Y; Zheng Y; Zhi Y; Chen D; Hong H; Li Q; Liu L; Meng Y; Wang N; Wang Y; Zhou Y; Zhang L;
    J Thorac Dis; 2017 Nov; 9(11):4607-4650. PubMed ID: 29268533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepwise approach towards adoption of allergen immunotherapy for allergic rhinitis and asthma patients in daily practice in Belgium: a BelSACI-Abeforcal-EUFOREA statement.
    Hellings PW; Pugin B; Mariën G; Bachert C; Breynaert C; Bullens DM; Ceuppens JL; Clement G; Cox T; Ebo D; Gevaert P; Halewyck S; Hox V; Ladha K; Jacobs R; Rombaux P; Schrijvers R; Speleman K; Van der Brempt X; Van Gerven L; Vanderveken O; Verhaeghe B; Vierstraete K; Vlaminck S; Watelet JB; Bousquet J; Seys SF
    Clin Transl Allergy; 2019; 9():1. PubMed ID: 30740211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline on allergen immunotherapy in IgE-mediated allergic diseases: S2K Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), Society of Pediatric Allergology and Environmental Medicine (GPA), Medical Association of German Allergologists (AeDA), Austrian Society of Allergology and Immunology (ÖGAI), Swiss Society for Allergology and Immunology (SSAI), German Dermatological Society (DDG), German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), German Society of Pediatrics and Adolescent Medicine (DGKJ), Society of Pediatric Pulmonology (GPP), German Respiratory Society (DGP), German Professional Association of Otolaryngologists (BVHNO), German Association of Paediatric and Adolescent Care Specialists (BVKJ), Federal Association of Pneumologists, Sleep and Respiratory Physicians (BdP), Professional Association of German Dermatologists (BVDD).
    Pfaar O; Ankermann T; Augustin M; Bubel P; Böing S; Brehler R; Eng PA; Fischer PJ; Gerstlauer M; Hamelmann E; Jakob T; Kleine-Tebbe J; Kopp MV; Lau S; Mülleneisen N; Müller C; Nemat K; Pfützner W; Saloga J; Strömer K; Schmid-Grendelmeier P; Schuster A; Sturm GJ; Taube C; Szépfalusi Z; Vogelberg C; Wagenmann M; Wehrmann W; Werfel T; Wöhrl S; Worm M; Wedi B; ; Kaul S; Mahler V; Schwalfenberg A
    Allergol Select; 2022; 6():167-232. PubMed ID: 36178453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Evidence-based Medicine (EBM) Doesn't Say About Allergen-specific Immunotherapy (AIT).
    Di Lorenzo G; Melluso M; Rodolico A
    Transl Med UniSa; 2023; 25(1):1-10. PubMed ID: 38143507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [GUIMIT 2019, Mexican Guideline on Immunotherapy. Guideline on the diagnosis of IgE-mediated allergic disease and immunotherapy following the ADAPTE approach].
    Larenas-Linnemann D; Luna-Pech JA; Rodríguez-Pérez N; Rodríguez-González M; Arias-Cruz A; Blandón-Vijil MV; Costa-Domínguez MC; Del Río-Navarro BE; Estrada-Cardona A; Navarrete-Rodríguez EM; Ortega-Martell JA; Pozo-Beltrán CF; Brito-Díaz H; Canseco-Raymundo MR; Castelán-Chávez EE; Domínguez-Silva MG; Escalante-Domínguez AJ; Gálvez-Romero JL; García-Reyes MG; Gómez-Vera J; González-Díaz SN; Guerrero-Núñez MGB; Hernández-Colín D; Macías-Weinmann A; Mendoza-Hernández DA; Meneses-Sánchez NA; Mogica-Martínez MD; Moncayo-Coello CV; Montiel-Herrera M; O'Farril-Romanillos P; Onuma-Takane E; Ortega-Cisneros M; Rangel-Garza L; Stone-Aguilar H; Torres-Lozano C; Venegas-Montoya E; Wakida-Kusunoki G; Macouzet-Sánchez C; Partida-Gaytán A; López-García AI; Macías-Robles AP; Ambriz-Moreno MJ; Azamar-Jácome AA; Báez-Loyola C; Beltrán-De Paz CY; Caballero-López C; Fernández de Córdova-Aguirre JC; Fernández-Soto R; Lozano-Sáenz JS; Oyoqui-Flores JJ; Osorio-Escamilla R; Ramírez F; Rivero-Yeverino D; Orozco-Martínez MS; Rojo-Gutiérrez MI; Martínez E; Medina-Ávalos MA
    Rev Alerg Mex; 2019; 66 Suppl 1():1-105. PubMed ID: 31200597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergen immunotherapy and asthma: efficacy, safety, and other considerations.
    Cox L
    Allergy Asthma Proc; 2008; 29(6):580-9. PubMed ID: 19173785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Efficacy of Allergen-Specific Immunotherapy from Patient and Physician Perspectives.
    Shin YS; Jung JW; Park JW; Choi JH; Kwon JW; Lee S; Kim JH; Lee SM; Ahn YM; Han MY;
    Yonsei Med J; 2019 May; 60(5):446-453. PubMed ID: 31016906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Allergen Immunotherapy for Allergic Asthma in Real World Practice.
    Rhyou HI; Nam YH
    Allergy Asthma Immunol Res; 2020 Jan; 12(1):99-109. PubMed ID: 31743967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma.
    Agache I; Lau S; Akdis CA; Smolinska S; Bonini M; Cavkaytar O; Flood B; Gajdanowicz P; Izuhara K; Kalayci O; Mosges R; Palomares O; Papadopoulos NG; Sokolowska M; Angier E; Fernandez-Rivas M; Pajno G; Pfaar O; Roberts GC; Ryan D; Sturm GJ; van Ree R; Varga EM; van Wijk RG; Yepes-Nuñez JJ; Jutel M
    Allergy; 2019 May; 74(5):855-873. PubMed ID: 31095767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) survey: provider practices and beliefs about allergen immunotherapy.
    Leatherman B; Skoner DP; Hadley JA; Walstein N; Blaiss MS; Dykewicz MS; Craig T; Smith N; Allen-Ramey F
    Int Forum Allergy Rhinol; 2014 Oct; 4(10):779-88. PubMed ID: 25123933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review.
    Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Macchia L; Di Lorenzo G
    Allergy; 2017 May; 72(5):691-704. PubMed ID: 27926981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric investigation plans for specific immunotherapy: Questionable contributions to childhood health.
    Rose K; Kopp MV
    Pediatr Allergy Immunol; 2015 Dec; 26(8):695-701. PubMed ID: 26495999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials in allergen immunotherapy in the age group of children and adolescents: current concepts and future needs.
    Pfaar O; Gerth van Wijk R; Klimek L; Bousquet J; Creticos PS
    Clin Transl Allergy; 2020; 10():11. PubMed ID: 32346471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.